PTN and cancer: Thus, these findings suggested that MARCKSL1 influences the progression of MVI and cancer malignancy through PTN-related signalling, which is supported by immunohistochemistry results from the Human Protein Atlas showing greater expression of MARCKSL1 in cancerous tissues than in adjacent noncancerous tissues (Figure 9H).